Radiotherapy versus low-dose tamoxifen following breast-conserving surgery for low-risk and estrogen receptor-positive breast ductal carcinoma in situ: an international open-label randomized non-inferiority trial (TBCC-ARO DCIS Trial)

BACKGROUND: Radiotherapy (RT) following breast-conserving surgery (BCS) is mainly used to decrease the rate of ipsilateral breast tumor recurrence (IBTR) in women with breast ductal carcinoma in situ (DCIS). Recent studies have demonstrated that low-dose tamoxifen significantly reduces IBTR in breas...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuo, Sung-Hsin, Tseng, Ling-Ming, Chen, Shou-Tung, Sagara, Yasuaki, Chang, Yuan-Ching, Yeh, Hsien-Tang, Kuo, Yao-Lung, Hung, Chih-Chiang, Lu, Tzu-Pin, Lee, Yi-Hsuan, Toi, Masakazu, Huang, Chiun-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500726/
https://www.ncbi.nlm.nih.gov/pubmed/37710198
http://dx.doi.org/10.1186/s12885-023-11291-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500726/
https://www.ncbi.nlm.nih.gov/pubmed/37710198
http://dx.doi.org/10.1186/s12885-023-11291-6

Ejemplares similares